[1] Lund, V.J. and Milroy, C. (1993) Olfactory Neuroblastoma: Clinical and Pathological Aspects. Rhinology, 31, 1-6.
[2] Elkon, D. and Hightower, S.I. (1979) Esthesioneuroblastoma. Cancer, 44, 1087-1094.
http://dx.doi.org/10.1002/1097-0142(197909)44:3<1087::AID-CNCR2820440343>3.0.CO;2-A
[3] Palacios & Valvassori, 1998; Hwang, et al.; Tamase, et al., 2004; Lin, et al.; Ghaffar & Salahuddin, 2005; Yu, et al.; Iliades, et al., 2002; Thompson, 2009.
[4] Dulguerov, P., Allal, A.S. and Calcaterra, T.C. (2001) Esthesioneuroblastoma: A Meta Analysis and Review. The Lancet Oncology, 2, 683-690.
http://dx.doi.org/10.1016/S1470-2045(01)00558-7
[5] Mills, S.E. and Frierson Jr., H.F. (1985) Olfactory Neuroblastoma: A Clinicopathological Study of 21 Cases. The American Journal of Surgical Pathology, 9, 317-327.
http://dx.doi.org/10.1097/00000478-198505000-00001
[6] Batsakis, J.G. (1979) Tumors of the Head and Neck. 2nd Edition, Williams and Wilkins, Baltimore, 338-349.
[7] Wenig, B.M., Prasad, M.L., Dulguerov, P., Fanburg, J.C., Kapadia, S.B. and Thomson, L.D. (2005) Neuroectodermal tumors. In: Barnes, L., Eveson, J.W., Reichart, P. and Sidransky, D., Eds., WHO Classification of Tumors, Pathology and Genetics, Head and Neck Tumors, IARC Press, Lyon, 65-75.
[8] Thompson, L.D. (2009) Olfactory Neuroblastoma. Head and Neck Pathology, 3, 252-259.
http://dx.doi.org/10.1007/s12105-009-0125-2
[9] Menon, S., Pai, P., Sengar, M., Aggarwal, J.P. and Kane, S.V. (2010) Sinonasal Malignancies with Neuroendocrine Differentiation: Case Series and Review of Literature. Indian Journal of Pathology & Microbiology, 53, 28-34.
http://dx.doi.org/10.4103/0377-4929.59179
[10] Zhang, M., Zhou, L., Wang, D.H., Huang, W.T. and Wang, S.Y. (2010) Diagnosis and Management of Esthesioneuroblastoma. ORL: Journal for Oto-Rhino-Laryngology and Its Related Specialties, 72, 113-118.
http://dx.doi.org/10.1159/000278255
[11] Tabyaoui, I., Tahiri-Jouti, N., Serhier, Z., Bennani-Othmani, M., Sibai, H., Itri, M., Benchekroun, S. and Zamiati, S. (2013) Immunohistochemical Expression of CD44s in Human Neuroblastic Tumors: Moroccan Experience and Highlights on Current Data. Diagnostic Pathology, 8, 39.
http://dx.doi.org/10.1186/1746-1596-8-39
[12] Gore, M.R. and Zanation, A.M. (2009) Salvage Treatment of Late Neck Metastasis in Esthesioneuroblastoma: A Meta-Analysis. Archives of Otolaryngology—Head & Neck Surgery, 135, 1030-1034.
http://dx.doi.org/10.1001/archoto.2009.143
[13] Kane, A.J., Sughrue, M.E., Rutkowski, M.J., Aranda, D., Mills, S.A., Buencamino, R., Fang, S., Barani, I.J. and Parsa, A.T. (2010) Post Treatment Prognosis of Patients with Esthesioneuroblastoma. Journal of Neurosurgery, 113, 340-351.
http://dx.doi.org/10.3171/2010.2.JNS091897
[14] Platek, M.E., Merzianu, M., Mashtare, T.L., Popat, S.R., Rigual, N.R., Warren, G.W. and Singh, A.K. (2011) Improved Survival Following Surgery and Radiation Therapy for Olfactory Neuroblastoma: Analysis of the SEER Database. Radiation Oncology, 6, 41.
http://dx.doi.org/10.1186/1748-717X-6-41
[15] Kadish, S., Goodman, M. and Wang, C.C. (1976) Olfactory Neuroblastoma. A Clinical Analysis of 17 Cases. Cancer, 23, 1571-1676.
http://dx.doi.org/10.1002/1097-0142(197603)37:3<1571::AID-CNCR2820370347>3.0.CO;2-L